Velasco, Marelyn A.
HRN: 21-34-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/02/2022
07/08/2022
IV DRIP
230mg
Q6
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes